Carisma Therapeutics CEO Steven Kelly talks reverse merger, growth plans


Following a reverse merger with Sesen Bio, Philadelphia's Carisma Therapeutics plans to add as many as 30 new employees this year.

Previous Intuitive Health founder teases ‘strategic opportunity’ for urgent care, emergency room growth across Texas
Next Rio Bravo Brewing unveils AI-crafted 'Alegorithm' beer